Electromedical Technologies, Inc. EMED

Annual Quarterly

Q3 FY2024 · ended Sep 30, 2024 · Revenue $42,526, -86.9% YoY · Filed Nov 19, 2024

Electromedical Technologies, Inc. (EMED) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2024, the quarter ended Sep 30, 2024, it reported revenue of $42,526 and a net loss of $724,643. Free cash flow was -$180,534. As of Sep 30, 2024 it held $34,809 in cash and investments and $131,562 in total debt.

Revenue
$42,526
-86.9% vs year-ago quarter
Net income
$-724,643
-92.4% vs year-ago quarter
Operating cash flow
$-30,829
+88.9% vs year-ago quarter
Free cash flow
$-180,534
+57.8% vs year-ago quarter
EPS
$0.00
Dividend per share
None
Shares outstanding
855.04M
+84.6% vs year-ago quarter
Net cash
$-96,753
Q3 FY2024
Operating margin
-109.6%
TTM

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
EMED (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Scottsdale, AZ
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1715819

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Q3 FY2024
Sep 30, 2024
Q2 FY2024
Jun 30, 2024
Q1 FY2024
Mar 31, 2024
Q4 FY2023
Dec 31, 2023
Q3 FY2023
Sep 30, 2023
Revenue
$42,526
$237,645
$290,244
$351,595
$323,613
Operating income
-$381,038
-$251,845
-$154,876
-$222,971
-$239,029
Net income
-$724,643
$231,236
-$836,274
-$348,657
-$376,720
Diluted EPS
—
$0.00
-$0.00
-$0.00
$0.00
Operating cash flow
-$30,829
$108,927
-$158,361
-$50,948
-$277,779
Free cash flow
-$180,534
—
—
-$50,948
-$427,484
Total assets
$568,813
$664,959
$707,022
$748,383
$853,403
Total liabilities
$4.6M
$4.1M
$4.4M
$3.6M
$3.4M
Stockholders' equity
-$4.0M
-$3.4M
-$3.7M
-$2.9M
-$2.5M
Cash and investments
$34,809
$116,931
$78,843
$87,704
$138,477
Total debt
$131,562
$263,123
$286,866
$459,890
$166,106

Recent SEC filings

Form Description Filed Period
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024
10-K/A Amended annual report Oct 16, 2024 Dec 31, 2023
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K/A Amended current report
Bylaw or fiscal year change
 Aug 9, 2024 Jul 18, 2024
8-K Current report
Bylaw or fiscal year change
 Jul 24, 2024 Jul 18, 2024
10-Q Quarterly report Jun 14, 2024 Mar 31, 2024

All 136 Electromedical Technologies, Inc. SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.